Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration

European Journal of Cancer(2025)10.1016/j.ejca.2025.115629Source: DataRank Database

Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration is a research paper published in European Journal of Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (21)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (39)

Susan Chi ORCID,Theodore W Laetscht,Lynley V. Marshall ORCID,Elizabeth A. Raetz ORCID,Rani E. George ORCID

Live enrichment

PubMed:40680434

B-IT Foundation

greenLicense: other-oa

repositoryhttps://pure.amsterdamumc.nl/files/151109690/Paediatric-strategy-forum-for-medicinal-product-development-of-cyclin-dependent-kinase-inhibitors-in-children-and-adoles.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0959804925004113?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0959804925004113?httpAccept=text/plain

repositoryhttps://dspace.library.uu.nl/handle/1874/477797

MeSH Terms

HumansNeoplasmsCyclin-Dependent KinasesAntineoplastic AgentsProtein Kinase InhibitorsUnited States Food and Drug AdministrationAdolescentChildUnited StatesEuropeClinical Trials as TopicDrug Development

Keywords

CDK9Drug DevelopmentCancer TherapeuticsPaediatric OncologyCdk7CombinationsCdk4/6Paediatric Strategy ForumCdk12 And Cdk13 Inhibitors